Innova Captab Board OKs ₹50 Cr Land Acquisition

Board of Directors has accorded in-principle approval for the acquisition of land with an estimated investment of approximately ₹50 crore. The proposed land purchase forms part of the company’s strategic real estate expansion and plans for operational facility development. The Board will provide further updates once the final purchase or sale agreement is executed between the parties. This move aligns with Innova Captab’s broader growth strategy in the pharmaceutical manufacturing and CDMO space, aimed at supporting future capacity needs and strengthening its operational footprint. The in-principle clearance marks an important step towards enhancing the company’s long-term manufacturing and infrastructure capabilities. **Top stocks in the pharmaceuticals / CDMO industry:** Laurus Labs, Syngene International, and Divi’s Laboratories.